Regulation of FAT/CD36 mRNA gene expression by long chain fatty acids in the differentiated 3T3-L1 cells

Pediatric Surgery International

Volumn 23, Issue 7, 2007, Pages 675-683

  Yang, Yingkui ^a   Chen, Min ^a   Loux, Tara J ^a   Harmon, Carroll M ^a  

^a Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMOPALMITIC ACID; CD36 ANTIGEN; INSULIN; ISOPRENALINE; LONG CHAIN FATTY ACID; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEARIC ACID;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DOSE RESPONSE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD36; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS; GENE EXPRESSION REGULATION; INSULIN; ISOPROTERENOL; KINETICS; MICE; PALMITATES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEARIC ACIDS;

EID: 34347354191     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-007-1942-6     Document Type: Article

References (48)

1. Kopelman PG (2000) Obesity as a medical problem. Nature 404:635-643
2. Hotu S, Carter B, Watson P, Cutfield W, Cundy T (2004) Increasing prevalence of type 2 diabetes in adolescents. J Paediatr Child Health 40:201-204
3. Bhargava SK, Sachdev HS, Fall CH et al (2004) Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 350:865-875
4. Nammi S, Koka S, Chinnala KM, Boini KM (2004) Obesity: an overview on its current perspectives and treatment options. Nutr J 3:3
5. Kissebah AH, Krakower GR (1994) Regional adiposity and morbidity. Physiol Rev 74:761-811
6. Reaven GM (1993) Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44:121-131
7. Lean ME, Han TS, Seidell JC (1998) Impairment of health and quality of life in people with large waist circumference. Lancet 351:853-856
8. Han TS, van Leer EM, Seidell JC, Lean ME (1995) Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. Bmj 311:1401-1405
9. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L (1984) Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 289:1257-1261
10. Felber JP, Ferrannini E, Golay A et al (1987) Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341-1350
11. Fujioka S, Matsuzawa Y, Tokunaga K et al (1991) Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes 15:853-859
12. Dennis KE, Goldberg AP (1993) Differential effects of body fatness and body fat distribution on risk factor for cardiovascular disease in women. Impact of weight loss. Arterioscler Thromb 13:1487-1494
13. Okamoto F, Tanaka T, Sohmiya K, Kawamura K (1998) CD36 abnormality and impaired myocardial long-chain fatty acid uptake in patients with hypertrophic cardiomyopathy. Jpn Circ J 62:499-504
14. Lefebvre M, Paulweber B, Fajas L et al (1999) Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. J Endocrinol 162:331-340
15. Lowell BB (1999) PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function. Cell 99:239-242
16. Maeda N, Takahashi M, Funahashi T et al (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094-2099
17. Tanaka T, Sohmiya K, Kawamura K (1997) Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 29:121-127
18. Sfeir Z, Ibrahimi A, Amri E, Grimaldi P, Abumrad N (1997) Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport. Prostaglandins Leukot Essent Fatty Acids 57:17-21
19. Sfeir Z, Ibrahimi A, Amri E, Grimaldi P, Abumrad N (1999) CD36 antisense expression in 3T3-F442A preadipocytes. Mol Cell Biochem 192:3-8
20. Van Nieuwenhoven FA, Luiken JJ, De Jong YF, Grimaldi PA, van der Vusse GJ, Glatz JF (1998) Stable transfection of fatty acid translocase (CD36) in a rat heart muscle cell line (H9c2). J Lipid Res 39:2039-2047
21. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA (1993) Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268:17665-17668
22. Abumrad NA, Sfeir Z, Connelly MA, Coburn C (2000) Lipid transporters: membrane transport systems for cholesterol and fatty acids. Curr Opin Clin Nutr Metab Care 3:255-262
23. Abumrad N, Coburn C, Ibrahimi A (1999) Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim Biophys Acta 1441:4-13
24. Coburn CT, Hajri T, Ibrahimi A, Abumrad NA (2001) Role of CD36 in membrane transport and utilization of long-chain fatty acids by different tissues. J Mol Neurosci 16:117-21
25. Moore KJ, Rosen ED, Fitzgerald ML et al (2001) The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Nat Med 7:41-47
26. Koonen DP, Glatz JF, Bonen A, Luiken JJ (2005) Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim Biophys Acta 1736:163-180
27. Mackall JC, Student AK, Polakis SE, Lane MD (1976) Induction of lipogenesis during differentiation in a "preadipocyte" cell line. J Biol Chem 251:6462-6464
28. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
29. Courtneidge SA, Smith AE (1983) Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature 303:435-439
30. Schaffer JE, Lodish HF (1994) Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79:427-436
31. Chen M, Yang Y, Braunstein E, Georgeson KE, Harmon CM (2001) Gut expression and regulation of FAT/CD36: possible role in fatty acid transport in rat enterocytes. Am J Physiol Endocrinol Metab 281:E916-E923
32. Langin D (2006) Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res 53:482-491
33. Akahoshi T, Namai R, Murakami Y et al (2003) Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals. Arthritis Rheum 48:231-239
34. Yu S, Matsusue K, Kashireddy P et al (2003) Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem 278:498-505
35. Vosper H, Patel L, Graham TL et al (2001) The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages. J Biol Chem 276:44258-44265
36. Singh Ahuja H, Liu S, Crombie DL et al (2001) Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Mol Pharmacol 59:765-773
37. Wu Q, Ortegon AM, Tsang B, Doege H, Feingold KR, Stahl A (2006) FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. Mol Cell Biol 26:3455-3467
38. Man MZ, Hui TY, Schaffer JE, Lodish HF, Bernlohr DA (1996) Regulation of the murine adipocyte fatty acid transporter gene by insulin. Mol Endocrinol 10:1021-1028
39. Unterman TG, Fareeduddin A, Harris MA et al (1994) Hepatocyte nuclear factor-3 (HNF-3) binds to the insulin response sequence in the IGF binding protein-1 (IGFBP-1) promoter and enhances promoter function. Biochem Biophys Res Commun 203:1835-1841
40. Tebbey PW, McGowan KM, Stephens JM, Buttke TM, Pekala PH (1994) Arachidonic acid down-regulates the insulin-dependent glucose transporter gene (GLUT4) in 3T3-L1 adipocytes by inhibiting transcription and enhancing mRNA turnover. J Biol Chem 269:639-644
41. O'Brien RM, Noisin EL, Suwanichkul A et al (1995) Hepatic nuclear factor 3-and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes. Mol Cell Biol 15:1747-1758
42. Spiegelman BM, Choy L, Hotamisligil GS, Graves RA, Tontonoz P (1993) Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J Biol Chem 268:6823-6826
43. Facchini FS, Stoohs RA, Reaven GM (1996) Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 9:1013-1017
44. Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19:491-503
45. Boden G (2003) Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes 111:121-124
46. Fasshauer M, Klein J, Ueki K et al (2000) Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes. J Biol Chem 275:25494-25501
47. Fasshauer M, Klein J, Kriauciunas KM, Ueki K, Benito M, Kahn CR (2001) Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Mol Cell Biol 21:319-329
48. Teboul L, Febbraio M, Gaillard D, Amri EZ, Silverstein R, Grimaldi PA (2001) Structural and functional characterization of the mouse fatty acid translocase promoter: activation during adipose differentiation. Biochem J 360:305-312